Ridgewood Investments’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.74M | Buy |
3,209
+9
| +0.3% | +$5.07K | 0.65% | 43 |
|
|
2026
Q1 | $1.9M | Buy |
+3,200
| New | +$1.59M | 0.78% | 33 |
|
|
2025
Q3 | $1.34M | Hold |
3,200
| – | – | 0.57% | 51 |
|
|
2025
Q2 | $920K | Hold |
3,200
| – | – | 0.4% | 71 |
|
|
2025
Q1 | $986K | Hold |
3,200
| – | – | 0.46% | 62 |
|
|
2024
Q4 | $1.13M | Hold |
3,200
| – | – | 0.54% | 51 |
|
|
2024
Q3 | $1.15M | Hold |
3,200
| – | – | 0.57% | 50 |
|
|
2024
Q2 | $1.02M | Hold |
3,200
| – | – | 0.51% | 54 |
|
|
2024
Q1 | $735K | Hold |
3,200
| – | – | 0.39% | 80 |
|
|
2023
Q4 | $704K | Hold |
3,200
| – | – | 0.42% | 82 |
|
|
2023
Q3 | $723K | Hold |
3,200
| – | – | 0.47% | 72 |
|
|
2023
Q2 | $706K | Hold |
3,200
| – | – | 0.4% | 70 |
|
|
2023
Q1 | $717K | Hold |
3,200
| – | – | 0.44% | 57 |
|
|
2022
Q4 | $890K | Hold |
3,200
| – | – | 0.63% | 44 |
|
|
2022
Q3 | $670K | Hold |
3,200
| – | – | 0.56% | 53 |
|
|
2022
Q2 | $754K | Hold |
3,200
| – | – | 0.59% | 51 |
|
|
2022
Q1 | $574K | Hold |
3,200
| – | – | 0.38% | 91 |
|
|
2021
Q4 | $691K | Hold |
3,200
| – | – | 0.44% | 77 |
|
|
2021
Q3 | $591K | Hold |
3,200
| – | – | 0.4% | 87 |
|
|
2021
Q2 | $574K | Hold |
3,200
| – | – | 0.37% | 97 |
|
|
2021
Q1 | $535K | Hold |
3,200
| – | – | 0.33% | 102 |
|
|
2020
Q4 | $323K | Hold |
3,200
| – | – | 0.25% | 119 |
|
|
2020
Q3 | $323K | Hold |
3,200
| – | – | 0.25% | 120 |
|
|
2020
Q2 | $387K | Hold |
3,200
| – | – | 0.32% | 107 |
|
|
2020
Q1 | $303K | Hold |
3,200
| – | – | 0.31% | 102 |
|
|
2019
Q4 | $282K | Hold |
3,200
| – | – | 0.2% | 140 |
|
|
2019
Q3 | $255K | Hold |
3,200
| – | – | 0.2% | 141 |
|
|
2019
Q2 | $250K | Hold |
3,200
| – | – | 0.2% | 145 |
|
|
2019
Q1 | $376K | Hold |
3,200
| – | – | 0.31% | 99 |
|
|
2018
Q4 | $409K | Hold |
3,200
| – | – | 0.33% | 92 |
|
|
2018
Q3 | $409K | Hold |
3,200
| – | – | 0.33% | 93 |
|
|
2018
Q2 | $362K | Hold |
3,200
| – | – | 0.32% | 94 |
|
|
2018
Q1 | $360K | Hold |
3,200
| – | – | 0.33% | 89 |
|
|
2017
Q4 | $473K | Hold |
3,200
| – | – | 0.42% | 72 |
|
|
2017
Q3 | $375K | Hold |
3,200
| – | – | 0.36% | 80 |
|
|
2017
Q2 | $415K | Hold |
3,200
| – | – | 0.42% | 69 |
|
|
2017
Q1 | $433K | Hold |
3,200
| – | – | 0.47% | 61 |
|
|
2016
Q4 | $458K | Buy |
+3,200
| New | +$409K | 0.54% | 52 |
|
Other funds holding UTHR
ACA
JT
Ridgewood Investments's UTHR Position: Q2 2026 in Review
Ridgewood Investments increased its United Therapeutics (UTHR) stake by 0.28% in Q2 2026, buying an estimated $5.07K and bringing the position to 3,209 shares worth $1.74M. The position accounts for 0.65% of the portfolio, ranked #43.
Ridgewood Investments first reported a position in UTHR in Q4 2016 and has held it in 38 quarters since. The position peaked at $1.9M in Q1 2026. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Ridgewood Investments held 3,209 shares of United Therapeutics worth $1.74M as of Q2 2026.
- Ridgewood Investments bought 9 United Therapeutics shares in Q2 2026, an estimated $5.07K.
- United Therapeutics made up 0.65% of Ridgewood Investments's portfolio in Q2 2026, its #43 holding.
- Ridgewood Investments first reported a position in United Therapeutics in Q4 2016 and has held it in 38 quarters since.
- Ridgewood Investments's United Therapeutics position peaked at $1.9M in Q1 2026.
- 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Ridgewood Investments's 13F filing for Q2 2026, filed 3 Aug 2026.